AAAAAA

   
Results: 1-7 |
Results: 7
THE EFFICACY OF ORAL CYPROTERONE-ACETATE IN COMBINATION WITH ETHINYLESTRADIOL IN ACNE TARDA OF THE FACIAL TYPE
Authors: GOLLNICK H ALBRING M BRILL K
Citation: H. Gollnick et al., THE EFFICACY OF ORAL CYPROTERONE-ACETATE IN COMBINATION WITH ETHINYLESTRADIOL IN ACNE TARDA OF THE FACIAL TYPE, Journal of dermatological treatment, 9(2), 1998, pp. 71-79
GESTODENE AND DESOGESTREL DO NOT HAVE A DIFFERENT INFLUENCE ON CONCENTRATION PROFILES OF ETHINYLESTRADIOL IN WOMEN TAKING ORAL-CONTRACEPTIVES - RESULTS OF ISOTOPE-DILUTION MASS-SPECTROMETRY MEASUREMENTS
Authors: SIEKMANN L SIEKMANN A BIDLINGMAIER F BRILL K ALBRING M
Citation: L. Siekmann et al., GESTODENE AND DESOGESTREL DO NOT HAVE A DIFFERENT INFLUENCE ON CONCENTRATION PROFILES OF ETHINYLESTRADIOL IN WOMEN TAKING ORAL-CONTRACEPTIVES - RESULTS OF ISOTOPE-DILUTION MASS-SPECTROMETRY MEASUREMENTS, European journal of endocrinology, 139(2), 1998, pp. 167-177
ACTIVATION OF BLOOD-CLOTTING AND FIBRINOL YSIS IN ANGIOCARDIOGRAPHY WITH IONIC AND NONIONIC CONTRAST-MEDIUM
Authors: WINKLER UH PARK JW WEBER S KOTHE A SCHNITKER J BEHRENDSSTEINS B ALBRING M
Citation: Uh. Winkler et al., ACTIVATION OF BLOOD-CLOTTING AND FIBRINOL YSIS IN ANGIOCARDIOGRAPHY WITH IONIC AND NONIONIC CONTRAST-MEDIUM, RoFo. Fortschritte auf dem Gebiete der Rontgenstrahlen und der neuenbildgebenden Verfahren, 166(6), 1997, pp. 539-543
A MULTICENTER, UNCONTROLLED CLINICAL INVESTIGATION OF THE CONTRACEPTIVE EFFICACY, CYCLE CONTROL, AND SAFETY OF A NEW LOW-DOSE ORAL-CONTRACEPTIVE CONTAINING 20 MU-G ETHINYL ESTRADIOL AND 100 MU-G LEVONORGESTRELOVER 6 TREATMENT CYCLES
Authors: BANNEMERSCHULT R HANKER JP WUNSCH C FOX P ALBRING M BRILL K
Citation: R. Bannemerschult et al., A MULTICENTER, UNCONTROLLED CLINICAL INVESTIGATION OF THE CONTRACEPTIVE EFFICACY, CYCLE CONTROL, AND SAFETY OF A NEW LOW-DOSE ORAL-CONTRACEPTIVE CONTAINING 20 MU-G ETHINYL ESTRADIOL AND 100 MU-G LEVONORGESTRELOVER 6 TREATMENT CYCLES, Contraception, 56(5), 1997, pp. 285-290
TREATMENT OF PATIENTS WITH PERIPHERAL ARTERIAL OCCLUSIVE DISEASE FONTAINE STAGE-III AND STAGE-IV WITH INTRAVENOUS ILOPROST - AN OPEN STUDY IN 900 PATIENTS
Authors: STABEN P ALBRING M
Citation: P. Staben et M. Albring, TREATMENT OF PATIENTS WITH PERIPHERAL ARTERIAL OCCLUSIVE DISEASE FONTAINE STAGE-III AND STAGE-IV WITH INTRAVENOUS ILOPROST - AN OPEN STUDY IN 900 PATIENTS, Prostaglandins, leukotrienes and essential fatty acids, 54(5), 1996, pp. 327-333
THE INFLUENCE OF THE DOSE OF ETHINYLESTRADIOL IN ORAL-CONTRACEPTIVES ON FOLLICLE GROWTH
Authors: TEICHMANN AT BRILL K ALBRING M SCHNITKER J WOJTYNEK P KUSTRA E
Citation: At. Teichmann et al., THE INFLUENCE OF THE DOSE OF ETHINYLESTRADIOL IN ORAL-CONTRACEPTIVES ON FOLLICLE GROWTH, Gynecological endocrinology, 9(4), 1995, pp. 299-305
CLINICAL-EXPERIENCE WITH A MODERN LOW-DOSE GESTODENE-CONTAINING ORAL-CONTRACEPTIVE IN ADOLESCENTS
Authors: BRILL K SCHNITKER J ALBRING M
Citation: K. Brill et al., CLINICAL-EXPERIENCE WITH A MODERN LOW-DOSE GESTODENE-CONTAINING ORAL-CONTRACEPTIVE IN ADOLESCENTS, Advances in contraception, 10(4), 1994, pp. 237-247
Risultati: 1-7 |